Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-23-032276

Options or other derivatives

  • Director acquired 24,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kersten Dirk Director 2023-05-24 Grant or award · Stock Option (right to buy) +24,900 24,900 D
Loading xslF345X04/doc4.xml…